Innsbruck, Austria

Johannes Leierer



 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Johannes Leierer in Mucoadhesive Polymers

Introduction

Johannes Leierer is an accomplished inventor based in Innsbruck, Austria. He has made significant contributions to the field of mucoadhesive polymers, particularly through his innovative approaches to enhancing their properties. With a total of two patents to his name, Leierer has focused on the intersection of polymer chemistry and biomedical applications.

Latest Patents

Leierer’s latest patents revolve around the development of mucoadhesive polymers that incorporate vitamin B partial structures. These innovations leverage the formation of disulfide bridges with mucus glycoproteins, which significantly improve the mucoadhesive properties of polymeric compounds. By covalently attaching thiol substructures to these polymers, the reactivity of free thiol groups is enhanced. This transformation into disulfides with mercaptonicotinamides or mercaptopyridoxins results in polymers that do not require protection against oxidation and exhibit higher permeation-enhancing properties.

Career Highlights

Throughout his career, Johannes Leierer has worked with notable companies in the pharmaceutical and research sectors. His experience includes positions at Croma Pharma GmbH and Thiomatrix Forschungs- und Beratungs GmbH. These roles have allowed him to apply his expertise in polymer science to real-world applications, contributing to advancements in drug delivery systems.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Johannes Leierer’s work in the field of mucoadhesive polymers showcases his innovative spirit and dedication to improving biomedical applications. His patents reflect a deep understanding of polymer chemistry and its potential to enhance drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…